Feline Diabetes: SGLT2 Inhibitor FAQs with Dr. Mott

When a new drug class enters the veterinary world, first comes the excitement…then comes the learning. In this episode of Clinician’s Brief Partner Podcast, Jocelyn Mott, DVM, DACVIM, answers your most frequently asked questions when it comes to using a novel drug class in the treatment of feline diabetes mellitus: the sodium-glucose cotransporter-2 inhibitor. Tune in as she explains when, how, and why to consider this option in newly diagnosed feline diabetics.Sponsored by ElancoResource:https://my.elanco.com/us/bexacatContact us:[email protected] to find us:Cliniciansbrief.com/podcastsFacebook.com/clinciansbriefTwitter: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beth Molleson, DVM - HostTaylor Argo - Producer & Project Manager, Brief StudioRandall Stupka - Podcast Production & Sound Editing